Vital Therapies Prices Initial Public Offering at $12 per Share By: Benzinga via Benzinga April 16, 2014 at 17:50 PM EDT Vital Therapies, Inc. (NASDAQ: VTL), a biotherapeutic company developing a cell-based therapy targeting the treatment of acute liver ... Read More >> Related Stocks: Vital Therapies Inc